Daphne Zohar on becoming the CEO of Seaport Therapeutics and today's $100M series A
She describes working with Steven Paul again, the Glyph technology that is the backbone of Seaport's platform, and initial programs in the neuropsychiatry space.
Also look for unique social pages for BiotechTV U.
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.
Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.